|
NICE Denies Cancer Drugs, Citing Lack of Evidence
The UK’s National Institute for Health and Clinical Excellence (NICE) Appraisal Committee has recommended against paying for three cancer drugs, citing insufficient clinical evidence of benefits to support the high costs of the products.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives